Aberdeen Group’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.8M | Buy |
424,907
+160,170
| +61% | +$5.21M | 0.02% | 521 |
|
|
2025
Q1 | $10M | Buy |
264,737
+39,913
| +18% | +$1.51M | 0.02% | 563 |
|
|
2024
Q4 | $18.4M | Buy |
224,824
+141,994
| +171% | +$11.6M | 0.03% | 390 |
|
|
2024
Q3 | $9.46M | Sell |
82,830
-107,571
| -56% | -$12.3M | 0.02% | 533 |
|
|
2024
Q2 | $14.4M | Sell |
190,401
-3,831
| -2% | -$289K | 0.03% | 445 |
|
|
2024
Q1 | $13.3M | Hold |
194,232
| – | – | 0.03% | 502 |
|
|
2023
Q4 | $12.2M | Buy |
+194,232
| New | +$12.2M | 0.03% | 509 |
|